APOC3 and metabolic dysfunction-associated steatotic liver disease: Among the Chinese Han population, ApoC3 polymorphisms correlated with higher hepatic and circulating triglyceride levels and subsequently increased risk of NAFLD [50], and among diabetic Taiwanese participants, a polymorphism of the adiponectin gene rendering lower levels was associated with increased risk of NAFLD [51].